Iceland· IS-EU/1/97/057/001/IS

Quadramet

A samarium (153sm) lexidronam product containing samarium sm-153 lexidronam pentasodium, registered in Iceland by Cis bio international*. The same ATC class is registered in 8 of our 19 countries.

ATC V10BX02

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedQuadrametATCV10BX02REGISTER NO.IS-EU/1/97/057/001/ISPACKS LISTED0CHECKEDSeptember 29, 2026

Where it is registered

Samarium (153sm) lexidronam is registered in 8 of 19 countries.

Countries holding a registration under ATC V10BX02 (samarium (153sm) lexidronam), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 5 of them publish a price we can compare per daily dose

Samarium (153sm) lexidronam · ATC V10BX02

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Samarium SM-153 lexidronam pentasodium
Manufacturer
Cis bio international*
Country
Iceland (IS)
ATC code
V10BX02
ATC class
Samarium (153Sm) lexidronam
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Samarium (153sm) lexidronam in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All samarium (153sm) lexidronam products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Norway · Quadramet

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f2bb3b1b-f1cd-4977-8448-be9399717d03
GET /v1/drugs/f2bb3b1b-f1cd-4977-8448-be9399717d03?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Stungulyf, lausn",
  "source": "lyfjastofnun",
  "atc_raw": "V10BX02",
  "marketed": false,
  "strength": "1,3 GBq/ml",
  "ma_number": "EU/1/97/057/001/IS",
  "substance": "Samarium SM-153 lexidronam pentasodium",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
  "ma_issued_serial": "37757"
}

See everything about samarium (153sm) lexidronam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.